Signal Transduction and Targeted Therapy-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2127573, encodeId=1835212e57375, content=偏重的研究方向：肿瘤 经验分享：这本期刊和Cell Research、Cell Discovery相比如何，谁的未来潜力更大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0e872037104, createdName=爱的哥尔摩, createdTime=Fri Apr 21 23:55:02 CST 2023, time=2023-04-21, status=1, ipAttribution=Baden-Wurttemberg), GetPortalCommentsPageByObjectIdResponse(id=2198512, encodeId=5a1a21985122d, content=Under Consideration后6天左右收到主编邮件说分配了一个副主编协助Peer Review，希望给个机会呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Sun Apr 14 22:10:50 CST 2024, time=2024-04-14, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2101123, encodeId=8e382101123ef, content=请问中过的研友，这个杂志是不是编辑给了修稿的机会，就有很大概率接受?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=891b5192912, createdName=1471eab0m84暂无昵称, createdTime=Thu Nov 17 15:32:59 CST 2022, time=2022-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125873, encodeId=2d8e21258e302, content=偏重的研究方向：肝脏;肠道 经验分享：已经审稿两个月了，还没有信息，他们大杂志不会身高这么久给拒绝吧！！！！好漫长啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5668633584, createdName=ms6000001495294634, createdTime=Fri Apr 14 11:01:47 CST 2023, time=2023-04-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2160074, encodeId=0ff121600e444, content=Manuscript Under Consideration一般多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14938341371, createdName=ms6000001571479804, createdTime=Wed Sep 27 18:15:41 CST 2023, time=2023-09-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2105100, encodeId=80ef2105100ed, content=请问大家，一修后被拒的可能性有多大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=417, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed902172873, createdName=12056e7dm61(暂无昵称), createdTime=Fri Dec 09 16:43:03 CST 2022, time=2022-12-09, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2173758, encodeId=df9521e3758dd, content=我就说一个问题，编辑给我的回复是别人文章的回复，且申诉无效。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f53c2217040, createdName=tanbin9, createdTime=Fri Dec 08 18:43:30 CST 2023, time=2023-12-08, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2158609, encodeId=f885215860953, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：刚中了1篇纯基础的article,一审2个月左右，5个审稿人给了接近50条意见，修回加上补实验前后花了近8个月的时间，后续经历2审3审后最终接受，从投稿到最后文章online花了1年多的时间，总的感觉是挺难的，审稿人比较专业且严格，不过对文章的整体提升有很大帮助，编辑要求提供原始数据，对文章质量把控相当严格，很有挑战性，感兴趣的小伙伴加油！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d021976943, createdName=我是学霸2015, createdTime=Wed Sep 20 00:00:54 CST 2023, time=2023-09-20, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=957146, encodeId=8fff95e1460d, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：投的综述，一个月，回来四个审稿人意见，都很认真负责和专业，提出了一些新的观点，看得出是领域专家，也给予了我肯定，只可惜副主编觉得我不太符合综述应该大而全的特点，可能我更适合投minireview，感觉这个期刊很不错，很有前途, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Thu Apr 15 01:54:43 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153645, encodeId=a37a21536456c, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5925631659, createdName=ms2000001614595419, createdTime=Sat Aug 19 21:46:24 CST 2023, time=2023-08-19, status=1, ipAttribution=重庆)]

2023-04-21 爱的哥尔摩来自Baden-Wurttemberg

偏重的研究方向：肿瘤
经验分享：这本期刊和Cell Research、Cell Discovery相比如何，谁的未来潜力更大？

305 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2127573, encodeId=1835212e57375, content=偏重的研究方向：肿瘤 经验分享：这本期刊和Cell Research、Cell Discovery相比如何，谁的未来潜力更大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0e872037104, createdName=爱的哥尔摩, createdTime=Fri Apr 21 23:55:02 CST 2023, time=2023-04-21, status=1, ipAttribution=Baden-Wurttemberg), GetPortalCommentsPageByObjectIdResponse(id=2198512, encodeId=5a1a21985122d, content=Under Consideration后6天左右收到主编邮件说分配了一个副主编协助Peer Review，希望给个机会呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Sun Apr 14 22:10:50 CST 2024, time=2024-04-14, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2101123, encodeId=8e382101123ef, content=请问中过的研友，这个杂志是不是编辑给了修稿的机会，就有很大概率接受?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=891b5192912, createdName=1471eab0m84暂无昵称, createdTime=Thu Nov 17 15:32:59 CST 2022, time=2022-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125873, encodeId=2d8e21258e302, content=偏重的研究方向：肝脏;肠道 经验分享：已经审稿两个月了，还没有信息，他们大杂志不会身高这么久给拒绝吧！！！！好漫长啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5668633584, createdName=ms6000001495294634, createdTime=Fri Apr 14 11:01:47 CST 2023, time=2023-04-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2160074, encodeId=0ff121600e444, content=Manuscript Under Consideration一般多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14938341371, createdName=ms6000001571479804, createdTime=Wed Sep 27 18:15:41 CST 2023, time=2023-09-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2105100, encodeId=80ef2105100ed, content=请问大家，一修后被拒的可能性有多大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=417, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed902172873, createdName=12056e7dm61(暂无昵称), createdTime=Fri Dec 09 16:43:03 CST 2022, time=2022-12-09, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2173758, encodeId=df9521e3758dd, content=我就说一个问题，编辑给我的回复是别人文章的回复，且申诉无效。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f53c2217040, createdName=tanbin9, createdTime=Fri Dec 08 18:43:30 CST 2023, time=2023-12-08, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2158609, encodeId=f885215860953, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：刚中了1篇纯基础的article,一审2个月左右，5个审稿人给了接近50条意见，修回加上补实验前后花了近8个月的时间，后续经历2审3审后最终接受，从投稿到最后文章online花了1年多的时间，总的感觉是挺难的，审稿人比较专业且严格，不过对文章的整体提升有很大帮助，编辑要求提供原始数据，对文章质量把控相当严格，很有挑战性，感兴趣的小伙伴加油！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d021976943, createdName=我是学霸2015, createdTime=Wed Sep 20 00:00:54 CST 2023, time=2023-09-20, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=957146, encodeId=8fff95e1460d, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：投的综述，一个月，回来四个审稿人意见，都很认真负责和专业，提出了一些新的观点，看得出是领域专家，也给予了我肯定，只可惜副主编觉得我不太符合综述应该大而全的特点，可能我更适合投minireview，感觉这个期刊很不错，很有前途, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Thu Apr 15 01:54:43 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153645, encodeId=a37a21536456c, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5925631659, createdName=ms2000001614595419, createdTime=Sat Aug 19 21:46:24 CST 2023, time=2023-08-19, status=1, ipAttribution=重庆)]

2024-04-14 H·D·E 来自重庆

Under Consideration后6天左右收到主编邮件说分配了一个副主编协助Peer Review，希望给个机会呀

12 0

[GetPortalCommentsPageByObjectIdResponse(id=2127573, encodeId=1835212e57375, content=偏重的研究方向：肿瘤 经验分享：这本期刊和Cell Research、Cell Discovery相比如何，谁的未来潜力更大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0e872037104, createdName=爱的哥尔摩, createdTime=Fri Apr 21 23:55:02 CST 2023, time=2023-04-21, status=1, ipAttribution=Baden-Wurttemberg), GetPortalCommentsPageByObjectIdResponse(id=2198512, encodeId=5a1a21985122d, content=Under Consideration后6天左右收到主编邮件说分配了一个副主编协助Peer Review，希望给个机会呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Sun Apr 14 22:10:50 CST 2024, time=2024-04-14, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2101123, encodeId=8e382101123ef, content=请问中过的研友，这个杂志是不是编辑给了修稿的机会，就有很大概率接受?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=891b5192912, createdName=1471eab0m84暂无昵称, createdTime=Thu Nov 17 15:32:59 CST 2022, time=2022-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125873, encodeId=2d8e21258e302, content=偏重的研究方向：肝脏;肠道 经验分享：已经审稿两个月了，还没有信息，他们大杂志不会身高这么久给拒绝吧！！！！好漫长啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5668633584, createdName=ms6000001495294634, createdTime=Fri Apr 14 11:01:47 CST 2023, time=2023-04-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2160074, encodeId=0ff121600e444, content=Manuscript Under Consideration一般多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14938341371, createdName=ms6000001571479804, createdTime=Wed Sep 27 18:15:41 CST 2023, time=2023-09-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2105100, encodeId=80ef2105100ed, content=请问大家，一修后被拒的可能性有多大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=417, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed902172873, createdName=12056e7dm61(暂无昵称), createdTime=Fri Dec 09 16:43:03 CST 2022, time=2022-12-09, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2173758, encodeId=df9521e3758dd, content=我就说一个问题，编辑给我的回复是别人文章的回复，且申诉无效。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f53c2217040, createdName=tanbin9, createdTime=Fri Dec 08 18:43:30 CST 2023, time=2023-12-08, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2158609, encodeId=f885215860953, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：刚中了1篇纯基础的article,一审2个月左右，5个审稿人给了接近50条意见，修回加上补实验前后花了近8个月的时间，后续经历2审3审后最终接受，从投稿到最后文章online花了1年多的时间，总的感觉是挺难的，审稿人比较专业且严格，不过对文章的整体提升有很大帮助，编辑要求提供原始数据，对文章质量把控相当严格，很有挑战性，感兴趣的小伙伴加油！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d021976943, createdName=我是学霸2015, createdTime=Wed Sep 20 00:00:54 CST 2023, time=2023-09-20, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=957146, encodeId=8fff95e1460d, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：投的综述，一个月，回来四个审稿人意见，都很认真负责和专业，提出了一些新的观点，看得出是领域专家，也给予了我肯定，只可惜副主编觉得我不太符合综述应该大而全的特点，可能我更适合投minireview，感觉这个期刊很不错，很有前途, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Thu Apr 15 01:54:43 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153645, encodeId=a37a21536456c, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5925631659, createdName=ms2000001614595419, createdTime=Sat Aug 19 21:46:24 CST 2023, time=2023-08-19, status=1, ipAttribution=重庆)]

2022-11-17 1471eab0m84暂无昵称

请问中过的研友，这个杂志是不是编辑给了修稿的机会，就有很大概率接受?

172 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2127573, encodeId=1835212e57375, content=偏重的研究方向：肿瘤 经验分享：这本期刊和Cell Research、Cell Discovery相比如何，谁的未来潜力更大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0e872037104, createdName=爱的哥尔摩, createdTime=Fri Apr 21 23:55:02 CST 2023, time=2023-04-21, status=1, ipAttribution=Baden-Wurttemberg), GetPortalCommentsPageByObjectIdResponse(id=2198512, encodeId=5a1a21985122d, content=Under Consideration后6天左右收到主编邮件说分配了一个副主编协助Peer Review，希望给个机会呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Sun Apr 14 22:10:50 CST 2024, time=2024-04-14, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2101123, encodeId=8e382101123ef, content=请问中过的研友，这个杂志是不是编辑给了修稿的机会，就有很大概率接受?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=891b5192912, createdName=1471eab0m84暂无昵称, createdTime=Thu Nov 17 15:32:59 CST 2022, time=2022-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125873, encodeId=2d8e21258e302, content=偏重的研究方向：肝脏;肠道 经验分享：已经审稿两个月了，还没有信息，他们大杂志不会身高这么久给拒绝吧！！！！好漫长啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5668633584, createdName=ms6000001495294634, createdTime=Fri Apr 14 11:01:47 CST 2023, time=2023-04-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2160074, encodeId=0ff121600e444, content=Manuscript Under Consideration一般多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14938341371, createdName=ms6000001571479804, createdTime=Wed Sep 27 18:15:41 CST 2023, time=2023-09-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2105100, encodeId=80ef2105100ed, content=请问大家，一修后被拒的可能性有多大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=417, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed902172873, createdName=12056e7dm61(暂无昵称), createdTime=Fri Dec 09 16:43:03 CST 2022, time=2022-12-09, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2173758, encodeId=df9521e3758dd, content=我就说一个问题，编辑给我的回复是别人文章的回复，且申诉无效。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f53c2217040, createdName=tanbin9, createdTime=Fri Dec 08 18:43:30 CST 2023, time=2023-12-08, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2158609, encodeId=f885215860953, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：刚中了1篇纯基础的article,一审2个月左右，5个审稿人给了接近50条意见，修回加上补实验前后花了近8个月的时间，后续经历2审3审后最终接受，从投稿到最后文章online花了1年多的时间，总的感觉是挺难的，审稿人比较专业且严格，不过对文章的整体提升有很大帮助，编辑要求提供原始数据，对文章质量把控相当严格，很有挑战性，感兴趣的小伙伴加油！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d021976943, createdName=我是学霸2015, createdTime=Wed Sep 20 00:00:54 CST 2023, time=2023-09-20, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=957146, encodeId=8fff95e1460d, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：投的综述，一个月，回来四个审稿人意见，都很认真负责和专业，提出了一些新的观点，看得出是领域专家，也给予了我肯定，只可惜副主编觉得我不太符合综述应该大而全的特点，可能我更适合投minireview，感觉这个期刊很不错，很有前途, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Thu Apr 15 01:54:43 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153645, encodeId=a37a21536456c, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5925631659, createdName=ms2000001614595419, createdTime=Sat Aug 19 21:46:24 CST 2023, time=2023-08-19, status=1, ipAttribution=重庆)]

2023-04-14 ms6000001495294634 来自天津

偏重的研究方向：肝脏;肠道
经验分享：已经审稿两个月了，还没有信息，他们大杂志不会身高这么久给拒绝吧！！！！好漫长啊

307 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=2127573, encodeId=1835212e57375, content=偏重的研究方向：肿瘤 经验分享：这本期刊和Cell Research、Cell Discovery相比如何，谁的未来潜力更大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0e872037104, createdName=爱的哥尔摩, createdTime=Fri Apr 21 23:55:02 CST 2023, time=2023-04-21, status=1, ipAttribution=Baden-Wurttemberg), GetPortalCommentsPageByObjectIdResponse(id=2198512, encodeId=5a1a21985122d, content=Under Consideration后6天左右收到主编邮件说分配了一个副主编协助Peer Review，希望给个机会呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Sun Apr 14 22:10:50 CST 2024, time=2024-04-14, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2101123, encodeId=8e382101123ef, content=请问中过的研友，这个杂志是不是编辑给了修稿的机会，就有很大概率接受?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=891b5192912, createdName=1471eab0m84暂无昵称, createdTime=Thu Nov 17 15:32:59 CST 2022, time=2022-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125873, encodeId=2d8e21258e302, content=偏重的研究方向：肝脏;肠道 经验分享：已经审稿两个月了，还没有信息，他们大杂志不会身高这么久给拒绝吧！！！！好漫长啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5668633584, createdName=ms6000001495294634, createdTime=Fri Apr 14 11:01:47 CST 2023, time=2023-04-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2160074, encodeId=0ff121600e444, content=Manuscript Under Consideration一般多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14938341371, createdName=ms6000001571479804, createdTime=Wed Sep 27 18:15:41 CST 2023, time=2023-09-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2105100, encodeId=80ef2105100ed, content=请问大家，一修后被拒的可能性有多大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=417, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed902172873, createdName=12056e7dm61(暂无昵称), createdTime=Fri Dec 09 16:43:03 CST 2022, time=2022-12-09, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2173758, encodeId=df9521e3758dd, content=我就说一个问题，编辑给我的回复是别人文章的回复，且申诉无效。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f53c2217040, createdName=tanbin9, createdTime=Fri Dec 08 18:43:30 CST 2023, time=2023-12-08, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2158609, encodeId=f885215860953, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：刚中了1篇纯基础的article,一审2个月左右，5个审稿人给了接近50条意见，修回加上补实验前后花了近8个月的时间，后续经历2审3审后最终接受，从投稿到最后文章online花了1年多的时间，总的感觉是挺难的，审稿人比较专业且严格，不过对文章的整体提升有很大帮助，编辑要求提供原始数据，对文章质量把控相当严格，很有挑战性，感兴趣的小伙伴加油！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d021976943, createdName=我是学霸2015, createdTime=Wed Sep 20 00:00:54 CST 2023, time=2023-09-20, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=957146, encodeId=8fff95e1460d, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：投的综述，一个月，回来四个审稿人意见，都很认真负责和专业，提出了一些新的观点，看得出是领域专家，也给予了我肯定，只可惜副主编觉得我不太符合综述应该大而全的特点，可能我更适合投minireview，感觉这个期刊很不错，很有前途, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Thu Apr 15 01:54:43 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153645, encodeId=a37a21536456c, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5925631659, createdName=ms2000001614595419, createdTime=Sat Aug 19 21:46:24 CST 2023, time=2023-08-19, status=1, ipAttribution=重庆)]

2023-09-27 ms6000001571479804 来自湖北省

Manuscript Under Consideration一般多久呀

207 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2127573, encodeId=1835212e57375, content=偏重的研究方向：肿瘤 经验分享：这本期刊和Cell Research、Cell Discovery相比如何，谁的未来潜力更大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0e872037104, createdName=爱的哥尔摩, createdTime=Fri Apr 21 23:55:02 CST 2023, time=2023-04-21, status=1, ipAttribution=Baden-Wurttemberg), GetPortalCommentsPageByObjectIdResponse(id=2198512, encodeId=5a1a21985122d, content=Under Consideration后6天左右收到主编邮件说分配了一个副主编协助Peer Review，希望给个机会呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Sun Apr 14 22:10:50 CST 2024, time=2024-04-14, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2101123, encodeId=8e382101123ef, content=请问中过的研友，这个杂志是不是编辑给了修稿的机会，就有很大概率接受?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=891b5192912, createdName=1471eab0m84暂无昵称, createdTime=Thu Nov 17 15:32:59 CST 2022, time=2022-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125873, encodeId=2d8e21258e302, content=偏重的研究方向：肝脏;肠道 经验分享：已经审稿两个月了，还没有信息，他们大杂志不会身高这么久给拒绝吧！！！！好漫长啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5668633584, createdName=ms6000001495294634, createdTime=Fri Apr 14 11:01:47 CST 2023, time=2023-04-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2160074, encodeId=0ff121600e444, content=Manuscript Under Consideration一般多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14938341371, createdName=ms6000001571479804, createdTime=Wed Sep 27 18:15:41 CST 2023, time=2023-09-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2105100, encodeId=80ef2105100ed, content=请问大家，一修后被拒的可能性有多大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=417, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed902172873, createdName=12056e7dm61(暂无昵称), createdTime=Fri Dec 09 16:43:03 CST 2022, time=2022-12-09, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2173758, encodeId=df9521e3758dd, content=我就说一个问题，编辑给我的回复是别人文章的回复，且申诉无效。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f53c2217040, createdName=tanbin9, createdTime=Fri Dec 08 18:43:30 CST 2023, time=2023-12-08, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2158609, encodeId=f885215860953, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：刚中了1篇纯基础的article,一审2个月左右，5个审稿人给了接近50条意见，修回加上补实验前后花了近8个月的时间，后续经历2审3审后最终接受，从投稿到最后文章online花了1年多的时间，总的感觉是挺难的，审稿人比较专业且严格，不过对文章的整体提升有很大帮助，编辑要求提供原始数据，对文章质量把控相当严格，很有挑战性，感兴趣的小伙伴加油！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d021976943, createdName=我是学霸2015, createdTime=Wed Sep 20 00:00:54 CST 2023, time=2023-09-20, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=957146, encodeId=8fff95e1460d, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：投的综述，一个月，回来四个审稿人意见，都很认真负责和专业，提出了一些新的观点，看得出是领域专家，也给予了我肯定，只可惜副主编觉得我不太符合综述应该大而全的特点，可能我更适合投minireview，感觉这个期刊很不错，很有前途, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Thu Apr 15 01:54:43 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153645, encodeId=a37a21536456c, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5925631659, createdName=ms2000001614595419, createdTime=Sat Aug 19 21:46:24 CST 2023, time=2023-08-19, status=1, ipAttribution=重庆)]

2022-12-09 12056e7dm61(暂无昵称) 来自安徽省

请问大家，一修后被拒的可能性有多大？

417 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2127573, encodeId=1835212e57375, content=偏重的研究方向：肿瘤 经验分享：这本期刊和Cell Research、Cell Discovery相比如何，谁的未来潜力更大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0e872037104, createdName=爱的哥尔摩, createdTime=Fri Apr 21 23:55:02 CST 2023, time=2023-04-21, status=1, ipAttribution=Baden-Wurttemberg), GetPortalCommentsPageByObjectIdResponse(id=2198512, encodeId=5a1a21985122d, content=Under Consideration后6天左右收到主编邮件说分配了一个副主编协助Peer Review，希望给个机会呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Sun Apr 14 22:10:50 CST 2024, time=2024-04-14, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2101123, encodeId=8e382101123ef, content=请问中过的研友，这个杂志是不是编辑给了修稿的机会，就有很大概率接受?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=891b5192912, createdName=1471eab0m84暂无昵称, createdTime=Thu Nov 17 15:32:59 CST 2022, time=2022-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125873, encodeId=2d8e21258e302, content=偏重的研究方向：肝脏;肠道 经验分享：已经审稿两个月了，还没有信息，他们大杂志不会身高这么久给拒绝吧！！！！好漫长啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5668633584, createdName=ms6000001495294634, createdTime=Fri Apr 14 11:01:47 CST 2023, time=2023-04-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2160074, encodeId=0ff121600e444, content=Manuscript Under Consideration一般多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14938341371, createdName=ms6000001571479804, createdTime=Wed Sep 27 18:15:41 CST 2023, time=2023-09-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2105100, encodeId=80ef2105100ed, content=请问大家，一修后被拒的可能性有多大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=417, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed902172873, createdName=12056e7dm61(暂无昵称), createdTime=Fri Dec 09 16:43:03 CST 2022, time=2022-12-09, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2173758, encodeId=df9521e3758dd, content=我就说一个问题，编辑给我的回复是别人文章的回复，且申诉无效。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f53c2217040, createdName=tanbin9, createdTime=Fri Dec 08 18:43:30 CST 2023, time=2023-12-08, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2158609, encodeId=f885215860953, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：刚中了1篇纯基础的article,一审2个月左右，5个审稿人给了接近50条意见，修回加上补实验前后花了近8个月的时间，后续经历2审3审后最终接受，从投稿到最后文章online花了1年多的时间，总的感觉是挺难的，审稿人比较专业且严格，不过对文章的整体提升有很大帮助，编辑要求提供原始数据，对文章质量把控相当严格，很有挑战性，感兴趣的小伙伴加油！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d021976943, createdName=我是学霸2015, createdTime=Wed Sep 20 00:00:54 CST 2023, time=2023-09-20, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=957146, encodeId=8fff95e1460d, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：投的综述，一个月，回来四个审稿人意见，都很认真负责和专业，提出了一些新的观点，看得出是领域专家，也给予了我肯定，只可惜副主编觉得我不太符合综述应该大而全的特点，可能我更适合投minireview，感觉这个期刊很不错，很有前途, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Thu Apr 15 01:54:43 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153645, encodeId=a37a21536456c, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5925631659, createdName=ms2000001614595419, createdTime=Sat Aug 19 21:46:24 CST 2023, time=2023-08-19, status=1, ipAttribution=重庆)]

2023-12-08 tanbin9 来自江苏省

我就说一个问题，编辑给我的回复是别人文章的回复，且申诉无效。

162 0

[GetPortalCommentsPageByObjectIdResponse(id=2127573, encodeId=1835212e57375, content=偏重的研究方向：肿瘤 经验分享：这本期刊和Cell Research、Cell Discovery相比如何，谁的未来潜力更大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0e872037104, createdName=爱的哥尔摩, createdTime=Fri Apr 21 23:55:02 CST 2023, time=2023-04-21, status=1, ipAttribution=Baden-Wurttemberg), GetPortalCommentsPageByObjectIdResponse(id=2198512, encodeId=5a1a21985122d, content=Under Consideration后6天左右收到主编邮件说分配了一个副主编协助Peer Review，希望给个机会呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Sun Apr 14 22:10:50 CST 2024, time=2024-04-14, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2101123, encodeId=8e382101123ef, content=请问中过的研友，这个杂志是不是编辑给了修稿的机会，就有很大概率接受?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=891b5192912, createdName=1471eab0m84暂无昵称, createdTime=Thu Nov 17 15:32:59 CST 2022, time=2022-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125873, encodeId=2d8e21258e302, content=偏重的研究方向：肝脏;肠道 经验分享：已经审稿两个月了，还没有信息，他们大杂志不会身高这么久给拒绝吧！！！！好漫长啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5668633584, createdName=ms6000001495294634, createdTime=Fri Apr 14 11:01:47 CST 2023, time=2023-04-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2160074, encodeId=0ff121600e444, content=Manuscript Under Consideration一般多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14938341371, createdName=ms6000001571479804, createdTime=Wed Sep 27 18:15:41 CST 2023, time=2023-09-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2105100, encodeId=80ef2105100ed, content=请问大家，一修后被拒的可能性有多大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=417, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed902172873, createdName=12056e7dm61(暂无昵称), createdTime=Fri Dec 09 16:43:03 CST 2022, time=2022-12-09, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2173758, encodeId=df9521e3758dd, content=我就说一个问题，编辑给我的回复是别人文章的回复，且申诉无效。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f53c2217040, createdName=tanbin9, createdTime=Fri Dec 08 18:43:30 CST 2023, time=2023-12-08, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2158609, encodeId=f885215860953, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：刚中了1篇纯基础的article,一审2个月左右，5个审稿人给了接近50条意见，修回加上补实验前后花了近8个月的时间，后续经历2审3审后最终接受，从投稿到最后文章online花了1年多的时间，总的感觉是挺难的，审稿人比较专业且严格，不过对文章的整体提升有很大帮助，编辑要求提供原始数据，对文章质量把控相当严格，很有挑战性，感兴趣的小伙伴加油！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d021976943, createdName=我是学霸2015, createdTime=Wed Sep 20 00:00:54 CST 2023, time=2023-09-20, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=957146, encodeId=8fff95e1460d, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：投的综述，一个月，回来四个审稿人意见，都很认真负责和专业，提出了一些新的观点，看得出是领域专家，也给予了我肯定，只可惜副主编觉得我不太符合综述应该大而全的特点，可能我更适合投minireview，感觉这个期刊很不错，很有前途, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Thu Apr 15 01:54:43 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153645, encodeId=a37a21536456c, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5925631659, createdName=ms2000001614595419, createdTime=Sat Aug 19 21:46:24 CST 2023, time=2023-08-19, status=1, ipAttribution=重庆)]

2023-09-20 我是学霸2015 来自河南省

审稿速度:12.0 | 投稿命中率:25.0
经验分享：刚中了1篇纯基础的article,一审2个月左右，5个审稿人给了接近50条意见，修回加上补实验前后花了近8个月的时间，后续经历2审3审后最终接受，从投稿到最后文章online花了1年多的时间，总的感觉是挺难的，审稿人比较专业且严格，不过对文章的整体提升有很大帮助，编辑要求提供原始数据，对文章质量把控相当严格，很有挑战性，感兴趣的小伙伴加油！

198 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2127573, encodeId=1835212e57375, content=偏重的研究方向：肿瘤 经验分享：这本期刊和Cell Research、Cell Discovery相比如何，谁的未来潜力更大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0e872037104, createdName=爱的哥尔摩, createdTime=Fri Apr 21 23:55:02 CST 2023, time=2023-04-21, status=1, ipAttribution=Baden-Wurttemberg), GetPortalCommentsPageByObjectIdResponse(id=2198512, encodeId=5a1a21985122d, content=Under Consideration后6天左右收到主编邮件说分配了一个副主编协助Peer Review，希望给个机会呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Sun Apr 14 22:10:50 CST 2024, time=2024-04-14, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2101123, encodeId=8e382101123ef, content=请问中过的研友，这个杂志是不是编辑给了修稿的机会，就有很大概率接受?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=891b5192912, createdName=1471eab0m84暂无昵称, createdTime=Thu Nov 17 15:32:59 CST 2022, time=2022-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125873, encodeId=2d8e21258e302, content=偏重的研究方向：肝脏;肠道 经验分享：已经审稿两个月了，还没有信息，他们大杂志不会身高这么久给拒绝吧！！！！好漫长啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5668633584, createdName=ms6000001495294634, createdTime=Fri Apr 14 11:01:47 CST 2023, time=2023-04-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2160074, encodeId=0ff121600e444, content=Manuscript Under Consideration一般多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14938341371, createdName=ms6000001571479804, createdTime=Wed Sep 27 18:15:41 CST 2023, time=2023-09-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2105100, encodeId=80ef2105100ed, content=请问大家，一修后被拒的可能性有多大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=417, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed902172873, createdName=12056e7dm61(暂无昵称), createdTime=Fri Dec 09 16:43:03 CST 2022, time=2022-12-09, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2173758, encodeId=df9521e3758dd, content=我就说一个问题，编辑给我的回复是别人文章的回复，且申诉无效。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f53c2217040, createdName=tanbin9, createdTime=Fri Dec 08 18:43:30 CST 2023, time=2023-12-08, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2158609, encodeId=f885215860953, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：刚中了1篇纯基础的article,一审2个月左右，5个审稿人给了接近50条意见，修回加上补实验前后花了近8个月的时间，后续经历2审3审后最终接受，从投稿到最后文章online花了1年多的时间，总的感觉是挺难的，审稿人比较专业且严格，不过对文章的整体提升有很大帮助，编辑要求提供原始数据，对文章质量把控相当严格，很有挑战性，感兴趣的小伙伴加油！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d021976943, createdName=我是学霸2015, createdTime=Wed Sep 20 00:00:54 CST 2023, time=2023-09-20, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=957146, encodeId=8fff95e1460d, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：投的综述，一个月，回来四个审稿人意见，都很认真负责和专业，提出了一些新的观点，看得出是领域专家，也给予了我肯定，只可惜副主编觉得我不太符合综述应该大而全的特点，可能我更适合投minireview，感觉这个期刊很不错，很有前途, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Thu Apr 15 01:54:43 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153645, encodeId=a37a21536456c, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5925631659, createdName=ms2000001614595419, createdTime=Sat Aug 19 21:46:24 CST 2023, time=2023-08-19, status=1, ipAttribution=重庆)]

2021-04-15 科研小麻瓜

审稿速度:2.0 | 投稿命中率:5.0
经验分享：投的综述，一个月，回来四个审稿人意见，都很认真负责和专业，提出了一些新的观点，看得出是领域专家，也给予了我肯定，只可惜副主编觉得我不太符合综述应该大而全的特点，可能我更适合投minireview，感觉这个期刊很不错，很有前途

435 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2127573, encodeId=1835212e57375, content=偏重的研究方向：肿瘤 经验分享：这本期刊和Cell Research、Cell Discovery相比如何，谁的未来潜力更大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=305, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0e872037104, createdName=爱的哥尔摩, createdTime=Fri Apr 21 23:55:02 CST 2023, time=2023-04-21, status=1, ipAttribution=Baden-Wurttemberg), GetPortalCommentsPageByObjectIdResponse(id=2198512, encodeId=5a1a21985122d, content=Under Consideration后6天左右收到主编邮件说分配了一个副主编协助Peer Review，希望给个机会呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Sun Apr 14 22:10:50 CST 2024, time=2024-04-14, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2101123, encodeId=8e382101123ef, content=请问中过的研友，这个杂志是不是编辑给了修稿的机会，就有很大概率接受?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=891b5192912, createdName=1471eab0m84暂无昵称, createdTime=Thu Nov 17 15:32:59 CST 2022, time=2022-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125873, encodeId=2d8e21258e302, content=偏重的研究方向：肝脏;肠道 经验分享：已经审稿两个月了，还没有信息，他们大杂志不会身高这么久给拒绝吧！！！！好漫长啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5668633584, createdName=ms6000001495294634, createdTime=Fri Apr 14 11:01:47 CST 2023, time=2023-04-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2160074, encodeId=0ff121600e444, content=Manuscript Under Consideration一般多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14938341371, createdName=ms6000001571479804, createdTime=Wed Sep 27 18:15:41 CST 2023, time=2023-09-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2105100, encodeId=80ef2105100ed, content=请问大家，一修后被拒的可能性有多大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=417, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed902172873, createdName=12056e7dm61(暂无昵称), createdTime=Fri Dec 09 16:43:03 CST 2022, time=2022-12-09, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2173758, encodeId=df9521e3758dd, content=我就说一个问题，编辑给我的回复是别人文章的回复，且申诉无效。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f53c2217040, createdName=tanbin9, createdTime=Fri Dec 08 18:43:30 CST 2023, time=2023-12-08, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2158609, encodeId=f885215860953, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：刚中了1篇纯基础的article,一审2个月左右，5个审稿人给了接近50条意见，修回加上补实验前后花了近8个月的时间，后续经历2审3审后最终接受，从投稿到最后文章online花了1年多的时间，总的感觉是挺难的，审稿人比较专业且严格，不过对文章的整体提升有很大帮助，编辑要求提供原始数据，对文章质量把控相当严格，很有挑战性，感兴趣的小伙伴加油！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4d021976943, createdName=我是学霸2015, createdTime=Wed Sep 20 00:00:54 CST 2023, time=2023-09-20, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=957146, encodeId=8fff95e1460d, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：投的综述，一个月，回来四个审稿人意见，都很认真负责和专业，提出了一些新的观点，看得出是领域专家，也给予了我肯定，只可惜副主编觉得我不太符合综述应该大而全的特点，可能我更适合投minireview，感觉这个期刊很不错，很有前途, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Thu Apr 15 01:54:43 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153645, encodeId=a37a21536456c, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5925631659, createdName=ms2000001614595419, createdTime=Sat Aug 19 21:46:24 CST 2023, time=2023-08-19, status=1, ipAttribution=重庆)]

2023-08-19 ms2000001614595419 来自重庆

无

224 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务